skip to main content
Show Results with:

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial

Weisz, G. et al.

American heart journal. VOL 166; NUMBER 6, ; 2013, 953-959.e3 -- Elsevier Science B.V., Amsterdam Part 6; (pages 953-959.e3) -- 2013

Online access

Searching Remote Databases, Please Wait